NCT06616220View on ClinicalTrials.gov

Dexamethasone for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

January 30, 2026

Conditions
ScoliosisScoliosis IdiopathicScoliosis; Adolescence
Interventions
DRUG

Dexamethasone

administration of 0.5ml/kg of 0.2% ropivacaine with 0.1mg/kg Dexamethasone for the erector spine plane block

DRUG

0.9%NaCl

0.9% NaCl

Trial Locations (1)

61-545

Department of Spine Diseases and Pediatric Orthopedics, University of Medical Sciences, Poznań, Poland, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT06616220 - Dexamethasone for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery | Biotech Hunter | Biotech Hunter